Successful treatment of refractory cutaneous warts using topical 3% cidofovir in a child after heart transplant

J Heart Lung Transplant. 2014 Sep;33(9):971-2. doi: 10.1016/j.healun.2014.02.012. Epub 2014 Feb 14.

Authors

Aoife Cleary¹, Rosemarie Watson², Colin J McMahon¹

Affiliations

¹ Departments of Paediatric Cardiology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
² Departments of Dermatology, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.

PMID: 24726426
DOI: 10.1016/j.healun.2014.02.012

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Topical
Antiviral Agents / administration & dosage*
Antiviral Agents / therapeutic use
Child
Cidofovir
Cytosine / administration & dosage
Cytosine / analogs & derivatives*
Cytosine / therapeutic use
Dose-Response Relationship, Drug
Female
Graft Rejection / prevention & control
Heart Transplantation*
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use
Opportunistic Infections / drug therapy
Opportunistic Infections / etiology
Organophosphonates / administration & dosage*
Organophosphonates / therapeutic use
Postoperative Period
Treatment Outcome
Warts / drug therapy*
Warts / etiology

Substances

Antiviral Agents
Immunosuppressive Agents
Organophosphonates
Cytosine
Cidofovir